前收市價 | 66.50 |
開市 | 66.50 |
買盤 | 58.00 |
賣出價 | 62.90 |
拍板 | 540.00 |
到期日 | 2025-06-20 |
今日波幅 | 66.50 - 66.50 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.